CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase 2 Study of PXD101 in Platinum Resistant Epithelial Ovarian Tumors and Micropapillary/Borderline (LMP) Ovarian Tumors

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT00301756
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:36:49.544599+00:00
Published At: 2016-12-14T00:00:00+00:00
Record Updated At: 2018-08-20
Results Posted At: 2016-12-14
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Fallopian Tube Carcinoma", "Primary Peritoneal Carcinoma", "Recurrent Borderline Ovarian Surface Epithelial-Stromal Tumor", "Recurrent Ovarian Carcinoma", "Stage III Borderline Ovarian Surface Epithelial-Stromal Tumor", "Stage III Ovarian Cancer", "Stage IV Borderline Ovarian Surface Epithelial-Stromal Tumor", "Stage IV Ovarian Cancer"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2018-08-20"
protocolSection.identificationModule.nctId: "NCT00301756"
protocolSection.identificationModule.officialTitle: "A Phase 2 Study of PXD101 in Platinum Resistant Epithelial Ovarian Tumors and Micropapillary/Borderline (LMP) Ovarian Tumors"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2016-12-14"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.